Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Gianna Tabaro"'
Autor:
Sandro Pignata, Giovanni Scambia, Clorinda Schettino, Laura Arenare, Carmela Pisano, Davide Lombardi, Ugo De Giorgi, Claudia Andreetta, Saverio Cinieri, Carmine De Angelis, Domenico Priolo, Claudia Casanova, Marta Rosati, Filippo Greco, Elena Zafarana, Ilaria Schiavetto, Serafina Mammoliti, Sabrina Chiara Cecere, Vanda Salutari, Simona Scalone, Alberto Farolfi, Marilena Di Napoli, Domenica Lorusso, Piera Gargiulo, Daniela Califano, Daniela Russo, Anna Spina, Rossella De Cecio, Paolo Chiodini, Francesco Perrone, Valentina Accinno, Chiara Altavilla, Giovanna Antonelli, Grazia Artioli, Francesco Avola, Bonifacio Barbara, Valentina Barbato, Michele Bartoletti, Simona Bevilacqua, Roberto Bordonaro, Oriana Borghese, Gaetano Buonfanti, Floriana Camarda, Giuliana Canzanella, Vittoria Carbone, Maria Rita Carbone, Giulia Carlo Stella, Chiara Cassani, Fabrizio Castagna, Monica Cattaneo, Margherita Cinefra, Nicoletta Colombo, Serena Corsetti, Monia Dall'Agata, Maria D'Amico, Gennaro Daniele, Elvira De Marino, Giovanni De Matteis, Sabino De Placido, Gabriella Del Bene, Antonia Del Giudice, Francesca Del Monte, Michele Del Sesto, Maddalena Donini, Giuliana Drudi, Gianluca Falcone, Adolfo Favaretto, Giulia Ferrera, Manuela Florio, Valeria Forestieri, Maria Stella Gallo, Ciro Gallo, Francesca Garibaldi, Fabiana Gerevini, Viola Ghizzoni, Maria Olga Giganti, Anna Gimigliano, Elena Giudice, Nicoletta Gnocchi, Adriano Gravina, Stefano Greggi, Maria Laura Iaia, Annalisa Ilardi, Gelsomina Iovine, Gabriella Ippoliti, Giulia Irollo, Ilenia Isidori, Mariateresa Lapresa, Giuseppe Lavenia, Laura Longhitano, Bortot Lucia, Gabriella Luzi, Sara Mariano, Valentina Marino, Giovanna Marrapese, Marilena Martino, Roberta Matocci, Enrica Mazzoni, Daniela Mercuri, Maria Mirto, Giovanna Mollo, Abbondanza Montinaro, Marta Moscatelli, Anna Maria Mosconi, Lucia Musacchio, Nicoletta Nanni, Pamela Natalucci, Milena Sabrina Nicoloso, Michele Orditura, Gabriella Maria Parma, Rodolfo Passalacqua, Michela Pelone, Maria Teresa Perri, Bruno Perrucci, Alessandra Piancastelli, Maria Carmela Piccirillo, Antonio Piccolo, Stefania Rapisardi, Giorgia Ravaglia, Teresa Ribecco, Caterina Ricci, Marianna Roccio, Fiorella Romano, Daniela Sambataro, Alfonso Savio, Ada Sbriglia, Cono Scaffa, Concetta Sergi, Francesca Sgandurra, Roberto Sorio, Stefano Stabile, Gianna Tabaro, Margherita Tambaro, Stefano Tamberi, Angelica Tecchiato, Angela Maria Trujillo, Eleonora Zaccarelli
Publikováno v:
The Lancet Oncology. 24:286-296
Background: Adding immunotherapy to first-line chemotherapy might improve outcomes for patients with advanced or recurrent endometrial cancer. We aimed to compare carboplatin and paclitaxel versus avelumab plus carboplatin and paclitaxel as first-lin
Autor:
Federico Innocenti, Gianna Tabaro, Gianmaria Miolo, Blase N. Polite, Angela Buonadonna, Quan Mai, Elizabeth Gray, Bianca Posocco, Elena Marangon, Manish R. Sharma, Giuseppe Toffoli
Purpose: UGT1A1*28 confers a higher risk of toxicity in patients treated with irinotecan. Patients with *1/*1 and *1/*28 genotypes might tolerate higher than standard doses of irinotecan. We aimed to identify the MTD of irinotecan in patients with me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162e90e00c70a482c4f0179d719a3546
https://doi.org/10.1158/1078-0432.c.6526580
https://doi.org/10.1158/1078-0432.c.6526580
Autor:
Federico Innocenti, Gianna Tabaro, Gianmaria Miolo, Blase N. Polite, Angela Buonadonna, Quan Mai, Elizabeth Gray, Bianca Posocco, Elena Marangon, Manish R. Sharma, Giuseppe Toffoli
Supplementary Table 1. Toxicities during the first cycle of FOLFIRI plus bevacizumab. Number of patients (%) is indicated. Toxicities were included if they occurred in at least 10% of patients or if they were grade 3 or greater, and if they were at l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::764037d4fbc7d0552dbc6bfe121467a0
https://doi.org/10.1158/1078-0432.22467227
https://doi.org/10.1158/1078-0432.22467227
Autor:
Federico Innocenti, Gianna Tabaro, Gianmaria Miolo, Blase N. Polite, Angela Buonadonna, Quan Mai, Elizabeth Gray, Bianca Posocco, Elena Marangon, Manish R. Sharma, Giuseppe Toffoli
Supplementary Figure 1. Progression-free survival (PFS) overall (A), by UGT1A1 genotype (B), and by irinotecan dose (C).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c69f08ce269d124632fcf479daa7c20
https://doi.org/10.1158/1078-0432.22467224.v1
https://doi.org/10.1158/1078-0432.22467224.v1
Autor:
Cristina Mazzega-Fabbro, Jerry Polesel, Simon Spazzapan, Loretta Meneghetti, Debora Montagner, Gianna Tabaro, Michele Bartoletti, Fabio Puglisi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc4247af9df942f824f225cee7110647
https://hdl.handle.net/11390/1245485
https://hdl.handle.net/11390/1245485
Autor:
Angela Buonadonna, Gianna Tabaro, Giuseppe Toffoli, Elizabeth Gray, Blase N. Polite, Manish R. Sharma, Elena Marangon, Bianca Posocco, Gianmaria Miolo, Federico Innocenti, Quan Mai
Publikováno v:
Clinical Cancer Research. 23:918-924
Purpose: UGT1A1*28 confers a higher risk of toxicity in patients treated with irinotecan. Patients with *1/*1 and *1/*28 genotypes might tolerate higher than standard doses of irinotecan. We aimed to identify the MTD of irinotecan in patients with me
Autor:
F. Arizio, Francesca Vannini, Alessandro Di Costanzo, Rosita Cenna, Gianna Tabaro, Giuseppe Procopio, Veronica Franchina, Stefania Gori, Celeste Cagnazzo, Oriana Nanni
Publikováno v:
Tumori. 106(4)
Background: The Agenzia Italiana del Farmaco (AIFA) Determination 809/2015 sets all the requirements that clinical units and laboratories must meet in order to conduct phase I studies. Requirements include buildings, equipment, personnel, emergency m
Autor:
Darius Norkus, Eugenio Borsatti, Gianna Tabaro, Giovanni Boz, A. De Paoli, Umberto Ricardi, M. De Ridder, E. Dubaere, Pietro Gabriele, Elena Delmastro, Thierry Gevaert, Hendrik Everaert, Elisabetta Garibaldi, M.A. Mahé, Benedikt Engels, Fernando Munoz, Stefano Vagge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9de3022fd5ca5cf81f08d30a64481e9
https://biblio.vub.ac.be/vubir/preoperative-radiation-therapy-with-a-simultaneous-integrated-boost-compared-to-chemoradiotherapy-for-ct34-rectal-cancer-a-multicentric-randomized-study(a0948fc0-7903-4d84-a8b4-c82d842fdbe2).html
https://biblio.vub.ac.be/vubir/preoperative-radiation-therapy-with-a-simultaneous-integrated-boost-compared-to-chemoradiotherapy-for-ct34-rectal-cancer-a-multicentric-randomized-study(a0948fc0-7903-4d84-a8b4-c82d842fdbe2).html
Autor:
Gianna Tabaro, Elena Delmastro, Elisabetta Garibaldi, Fernando Munoz, Hendrik Everaert, Benedikt Engels, A. Sermeus, Darius Norkus, M.A. Mahé, Thierry Gevaert, Stefano Vagge, Giovanni Boz, A. De Paoli, M. De Ridder, Pietro Gabriele, Umberto Ricardi, Eugenio Borsatti
Publikováno v:
Radiotherapy and Oncology. 119
Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients
Autor:
Giuseppe Toffoli, Angela Buonadonna, Sergio Frustaci, Gianna Tabaro, Salvatore Tumolo, Giovanni Lo Re, Elisa Turchet, Elena Torrisi, Gianmaria Miolo, Giuseppe Corona
Publikováno v:
International Journal of Clinical Oncology. 18:510-516
A combination of docetaxel (D), oxaliplatin (O), and capecitabine (C) (DOC) was studied in this dose-escalation phase Ib trial in patients with untreated advanced gastric cancer. Dose-limiting toxicity (DLT) included any grade 4 hematological or any